by Clinical Neuropsychologist Online | Thursday, November 14, 2024 | Neuropsychology (general)
Neuropsychology, Vol 39(1), Jan 2025, 54-64; doi:10.1037/neu0000968Objective: Biomarker-specific interventions (e.g., for dementia) will necessitate an individualized approach to treatment. We have constructed a psychometric classifier to identify persons adversely...
by Clinical Neuropsychologist Online | Thursday, November 14, 2024 | Neuroscience
Basolateral amygdala (BLA) neurons are engaged by emotionally salient stimuli. An area of increasing interest is how BLA dynamics relate to evolving reward-seeking behavior, especially under situations of uncertainty or ambiguity. Here, we recorded the activity of...
by Clinical Neuropsychologist Online | Wednesday, November 13, 2024 | Dementia
Abstract INTRODUCTION We aimed to investigate which factors affect plasma biomarker levels via amyloid beta (Aβ)-independent or Aβ-dependent effects and improve the predictive performance of these biomarkers for Aβ positivity on positron emission tomography (PET)....
by Clinical Neuropsychologist Online | Wednesday, November 13, 2024 | Dementia
Abstract INTRODUCTION Interventions to treat speech-language difficulties in primary progressive aphasia (PPA) often use word accuracy as a highly comparable outcome. However, there are more constructs of importance to people with PPA that have received less...
by Clinical Neuropsychologist Online | Wednesday, November 13, 2024 | Dementia
Abstract Blood-based biomarkers continue to be explored for disease detection, monitoring of progression, and therapeutic outcomes as the diagnostic determination of Alzheimer’s Disease in Down Syndrome (DS-AD) remains challenging in clinical settings. This...